Trio AI Partners with AbbyPay, a Member of PCG, to Pioneer the Future of AI-Powered Payments

As artificial intelligence (AI) rapidly permeates industries worldwide, Trio AI Limited ('Trio AI'), a leading AI infrastructure service provider in Asia, signed a Memorandum of Understanding ('MoU') with AbbyPay, a POS-free digital payment brand under The Payment Cards Group Limited ('PCG'), a cloud-native payment processor and acquirer, on November 26. This marks the official commencement […]

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing

(TSX:CNE),(OTC US:CNNEF),(Other OTC:CNNEF),(BVC:CNEC),(BVC:CNEC.CL), CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company's 5.75% senior unsecured notes due 2028 (the “DIP Credit Agreement”) for debtor-in-possession financing

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing GlobeNewswire December 10, 2025 CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company's 5.75% senior

Terns Announces Pricing of Upsized $650 Million Public Offering

(NASDAQ:TERN), FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public offering price of $40.00 per share, before underwriting discounts and commissions. The

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

(NasdaqGM:KYMR), WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $602.0 million of shares of its common stock. Kymera is selling 7,000,000 shares of

Terns Announces Pricing of Upsized $650 Million Public Offering

Terns Announces Pricing of Upsized $650 Million Public Offering GlobeNewswire December 10, 2025 FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering GlobeNewswire December 10, 2025 WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $602.0

MindHYVE.ai™ and Inter-University Council for East Africa Forge Transformative AI Partnership to Accelerate the Region’s Leap into the Future of Work

MindHYVE.ai, Inc. and the Inter-University Council for East Africa (IUCEA) have announced a groundbreaking partnership that positions East Africa as a leader in global AI fluency, ethical AI adoption, and workforce transformation. This collaboration marks one of the most ambitious regional initiatives for AI literacy and agentic learning ever undertaken on the African continent. https://mma.prnewswire.com/media/2842171/MindHYVE_ai_x_IUCEA.jpg

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRMB, PRMW

New York, New York–(Newsfile Corp. – December 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November

Scroll to Top